Parallel to the review programme on nevirapine currently taking place in Uganda under the guidance of the United States'€™ National Institutes of Health, the MCC in South Africa is conducting its own investigations locally at sites where nevirapine is being used for PMTCT. In our second and last instalment on the review effort, Khopotso Bodibe, explores the local segment of the investigation.